MedTrace Logo

Gastric Artery Embolization Trial for Lessening Appetite Nonsurgically

NCT02248688 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 5

Last updated 2022-01-25

Study results available
· View outcomes & findings →

Summary

The purpose of this pilot study is to achieve the collection of safety and efficacy data in patients undergoing left gastric artery embolization for morbid obesity in the United States. As secondary goal, the pilot study seeks to obtain quality of life data. This pilot study is not designed to achieve new indications for this device.

Conditions

  • Arterial Embolization
  • Other Surgical Procedures
  • Obesity

Interventions

DEVICE

BeadBlock 300 - 500 Micron

Beadblock will be used intraarterially to occlude the left gastric artery and its branches. The left gastric artery supplies the fundus of the stomach, where it is known that the hormone Ghrelin (one of the hormones responsible for appetite) is produced.

PROCEDURE

Left Gastric Artery Embolization

Sponsors & Collaborators

  • Ohio State University

    collaborator OTHER

  • Dayton Interventional Radiology

    lead OTHER

Principal Investigators

  • Mubin I Syed, MD · Dayton Interventional Radiology

  • Azim Shaikh, MD, MBA · Dayton Interventional Radiology

  • Sumeet Patel · Dayton Interventional Radiology

  • Feras J Deek, BS, BA · Dayton Interventional Radiology

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
22 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-09-30
Primary Completion
2019-11-30
Completion
2019-11-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02248688 on ClinicalTrials.gov